Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 15Vitamin D Deficiency 13Prostatic Neoplasms 13Polycystic Ovary Syndrome 8Neoplasms 7Osteoporosis 4Colorectal Neoplasms 4Warts 3Rectal Neoplasms 3Ovarian Neoplasms 3Myelodysplastic Syndromes 3Leukemia, Lymphocytic, Chronic, B-Cell 3Colonic Neoplasms 3Brain Neoplasms 3Male Urogenital Diseases 2Leukemia 2Cardiovascular Diseases 2Adenomatous Polyps 2Stroke 1Spinal Cord Injuries 1Skin Neoplasms 1Seizures 1Psoriasis 1Prostate Adenocarcinoma 1Premature Birth 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polyps 1Pathologic Processes 1Pain 1Osteoarthritis 1

Interventions

relacorilant 1pembrolizumab 1glutathione pegylated liposomal doxorubicin 1ficlatuzumab 1bosutinib 1Trastuzumab 1Pemetrexed 1Morphine 1Methadone 1MRX-2843 1Imatinib Mesylate 1Cholecalciferol 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pathologic Processes × Cholecalciferol × Clear all
NCT01166763 2016-07-18

Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D

University of Kansas Medical Center

Phase NA Completed
30 enrolled 10 charts
Breast

Breast Diseases, Breast Neoplasms, Hyperplasia, Neoplasms, Neoplasms by Site, Pathologic Processes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡